BR9612787A - Estratrienos de 17-difluormetileno - Google Patents
Estratrienos de 17-difluormetilenoInfo
- Publication number
- BR9612787A BR9612787A BR9612787-2A BR9612787A BR9612787A BR 9612787 A BR9612787 A BR 9612787A BR 9612787 A BR9612787 A BR 9612787A BR 9612787 A BR9612787 A BR 9612787A
- Authority
- BR
- Brazil
- Prior art keywords
- hydrogen atom
- alpha
- well
- beta position
- difluorethylene
- Prior art date
Links
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 150000003431 steroids Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J13/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17
- C07J13/007—Normal steroids containing carbon, hydrogen, halogen or oxygen having a carbon-to-carbon double bond from or to position 17 with double bond in position 17 (20)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Photoreceptors In Electrophotography (AREA)
- Exhaust-Gas Circulating Devices (AREA)
- Electrical Control Of Air Or Fuel Supplied To Internal-Combustion Engine (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Ceramic Products (AREA)
- Vehicle Body Suspensions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Patente de Invenção:<B>"ESTRATRIENOS DE 17-DIFLUORMETILENO"<D>. A presente invenção descreve os novos estratienos de 17-difluormetileno da fórmula geral I na qual R^ 1^ representa um átomo de hidrogênio ou um grupo C~ 1~- C~ 10~-alquila, R^ 5^ representa um grupo metila ou etila, bem como R^ 2^ representa um átomo de hidrogênio ou um grupo C~ 1~-C~ 10~-alquila em posição alfa ou beta, R^ 3^ representa um átomo de hidrogênio ou um grupo C~ 1~-C~ 10~-alquilóxi em posição alfa ou beta, R^ 4^ representa um átomo de hidrogênio em posição alfa ou beta, bem como A, B, D, E e G representam cada um átomo de hidrogênio, bem como eventualmente adicionalmente pelo menos um dos pares de substituintes G e R^ 2^, R^ 2^ e R^ 4^, R^ 4~ e A, A e R^ 3^, B e D, D e E representam uma dupla ligação. Os novos compostos dispõem de propriedades antioxidativas e protetoras vasculares até agora não descritas para esteróides e são adequados para a preparação de preparados farmacêuticos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19509729A DE19509729A1 (de) | 1995-03-13 | 1995-03-13 | 17-Difluormethylen-Estratriene |
| PCT/EP1996/001069 WO1996028462A1 (de) | 1995-03-13 | 1996-03-13 | 17-difluormethylen-estratriene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9612787A true BR9612787A (pt) | 1999-11-23 |
Family
ID=7756963
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9612787-2A BR9612787A (pt) | 1995-03-13 | 1996-03-13 | Estratrienos de 17-difluormetileno |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US6018062A (pt) |
| EP (1) | EP0815120B1 (pt) |
| JP (1) | JPH11501644A (pt) |
| KR (1) | KR19980703002A (pt) |
| AT (1) | ATE199159T1 (pt) |
| AU (1) | AU693335B2 (pt) |
| BR (1) | BR9612787A (pt) |
| CA (1) | CA2215201A1 (pt) |
| CZ (1) | CZ281097A3 (pt) |
| DE (2) | DE19509729A1 (pt) |
| HU (1) | HUP9801846A3 (pt) |
| IL (1) | IL117497A (pt) |
| IS (1) | IS4556A (pt) |
| NO (1) | NO308306B1 (pt) |
| PL (1) | PL322199A1 (pt) |
| RU (1) | RU2155770C2 (pt) |
| SI (1) | SI9620030A (pt) |
| SK (1) | SK121697A3 (pt) |
| TR (1) | TR199700950T1 (pt) |
| WO (1) | WO1996028462A1 (pt) |
| ZA (1) | ZA962037B (pt) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU703814B2 (en) * | 1995-12-04 | 1999-04-01 | Wyeth | Antioxidant |
| US5773432A (en) * | 1996-10-30 | 1998-06-30 | Schering Aktiengesellschaft | Method for lowering plasma levels of lipoprotein(a) |
| CN1820056A (zh) * | 2003-08-11 | 2006-08-16 | 雷吉亚纳化学工业有限公司 | 用于车体修理的化学组合物及其聚合方法 |
| US20080255076A1 (en) * | 2004-06-29 | 2008-10-16 | Jadolabs Gmbh | Steroid-Derived Pharmaceutical Compositions |
| US8030298B2 (en) | 2005-05-26 | 2011-10-04 | Abbott Products Gmbh | 17β-HSD1 and STS inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3741800A1 (de) * | 1987-12-07 | 1989-06-15 | Schering Ag | 17-halogenmethylen-estratriene |
| US5883087A (en) * | 1991-01-07 | 1999-03-16 | Pherin Corporation | Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods |
| US5783571A (en) * | 1991-01-07 | 1998-07-21 | Pherin Corporation | Method of altering hypothalamic function by nasal administration of estrene steroids |
| US5969168A (en) * | 1991-01-07 | 1999-10-19 | Pherin Corporation | Androstanes for inducing hypothalamic effects |
| US5773432A (en) * | 1996-10-30 | 1998-06-30 | Schering Aktiengesellschaft | Method for lowering plasma levels of lipoprotein(a) |
-
1995
- 1995-03-13 DE DE19509729A patent/DE19509729A1/de not_active Withdrawn
-
1996
- 1996-03-13 BR BR9612787-2A patent/BR9612787A/pt not_active Application Discontinuation
- 1996-03-13 EP EP96907453A patent/EP0815120B1/de not_active Expired - Lifetime
- 1996-03-13 JP JP8527276A patent/JPH11501644A/ja active Pending
- 1996-03-13 SK SK1216-97A patent/SK121697A3/sk unknown
- 1996-03-13 US US08/913,325 patent/US6018062A/en not_active Expired - Fee Related
- 1996-03-13 AU AU51078/96A patent/AU693335B2/en not_active Ceased
- 1996-03-13 ZA ZA962037A patent/ZA962037B/xx unknown
- 1996-03-13 CZ CZ972810A patent/CZ281097A3/cs unknown
- 1996-03-13 TR TR97/00950T patent/TR199700950T1/xx unknown
- 1996-03-13 HU HU9801846A patent/HUP9801846A3/hu unknown
- 1996-03-13 CA CA002215201A patent/CA2215201A1/en not_active Abandoned
- 1996-03-13 RU RU97116513/04A patent/RU2155770C2/ru active
- 1996-03-13 DE DE59606435T patent/DE59606435D1/de not_active Expired - Fee Related
- 1996-03-13 SI SI9620030A patent/SI9620030A/sl unknown
- 1996-03-13 WO PCT/EP1996/001069 patent/WO1996028462A1/de not_active Application Discontinuation
- 1996-03-13 AT AT96907453T patent/ATE199159T1/de not_active IP Right Cessation
- 1996-03-13 PL PL96322199A patent/PL322199A1/xx unknown
- 1996-03-13 KR KR1019970706410A patent/KR19980703002A/ko not_active Application Discontinuation
- 1996-03-14 IL IL11749796A patent/IL117497A/xx not_active IP Right Cessation
-
1997
- 1997-09-08 IS IS4556A patent/IS4556A/is unknown
- 1997-09-12 NO NO974206A patent/NO308306B1/no unknown
-
1999
- 1999-03-08 US US09/263,062 patent/US6136800A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996028462A1 (de) | 1996-09-19 |
| NO308306B1 (no) | 2000-08-28 |
| EP0815120A1 (de) | 1998-01-07 |
| NO974206L (no) | 1997-11-13 |
| HUP9801846A2 (hu) | 1998-12-28 |
| HUP9801846A3 (en) | 1999-03-01 |
| AU5107896A (en) | 1996-10-02 |
| EP0815120B1 (de) | 2001-02-14 |
| RU2155770C2 (ru) | 2000-09-10 |
| DE59606435D1 (de) | 2001-03-22 |
| US6018062A (en) | 2000-01-25 |
| IL117497A (en) | 1999-12-22 |
| IS4556A (is) | 1997-09-08 |
| SK121697A3 (en) | 1998-02-04 |
| ZA962037B (en) | 1996-09-25 |
| NO974206D0 (no) | 1997-09-12 |
| ATE199159T1 (de) | 2001-02-15 |
| PL322199A1 (en) | 1998-01-19 |
| CZ281097A3 (cs) | 1998-02-18 |
| TR199700950T1 (xx) | 1998-02-21 |
| US6136800A (en) | 2000-10-24 |
| JPH11501644A (ja) | 1999-02-09 |
| AU693335B2 (en) | 1998-06-25 |
| DE19509729A1 (de) | 1996-09-19 |
| MX9707006A (es) | 1997-11-29 |
| CA2215201A1 (en) | 1996-09-19 |
| IL117497A0 (en) | 1996-07-23 |
| KR19980703002A (ko) | 1998-09-05 |
| SI9620030A (sl) | 1998-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0014116A (pt) | Uso de um composto, composto, métodos para preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica | |
| BR9911013A (pt) | Derivados de pirazol como inibidores da p-38 map quinase | |
| BR0211227A (pt) | Composto, composição farmacêutica e seus usos | |
| BRPI0414514A (pt) | uso de um composto, composto, e, composições farmacêuticas | |
| BR9806413A (pt) | Composto e uso do mesmo | |
| BR9707064A (pt) | Novos derivados 19-nor-pregneno | |
| BR0215312A (pt) | Uso de um composto, método para inibir a aurora quinase em um animal de sangue quente, composto, composição farmacêutica, e, processo para a preparação de um composto | |
| AR102722A2 (es) | Un derivado de pirazolo-quinazolina, su uso, un procedimiento para prepararlos, composiciones farmacéuticas que los comprenden, compuestos utilizables en su preparación, una biblioteca de dos o más compuestos, y un producto o kit | |
| BR0206955A (pt) | Ligantes de receptores de canabinóides | |
| BR0014137A (pt) | Composto, método para inibir a aurora 2 quinase em um animal de sangue quente, uso de um composto, e, composição farmacêutica | |
| BR0208678A (pt) | Composto, composição farmacêutica, uso de um composto | |
| AR023423A1 (es) | Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos | |
| YU149791A (sh) | Mometason, furoat monohidrat i postupak za njegovo dobijanje | |
| BR9913592A (pt) | Compostos, processo de preparação dos compostos, e, composições farmacêuticas | |
| BR0010520A (pt) | Novos compostos farmaceuticamente ativos | |
| BR9910573A (pt) | Compostos antipicornavirais, preparação e uso dos mesmos | |
| BRPI0406801B8 (pt) | derivados de tieno-pirimidinodiona e uso dos mesmos na modulação de doenças autoimunes | |
| AR045040A1 (es) | Derivados de compuestos espiroazabiciclicos, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos | |
| BRPI0410669A (pt) | inibidores de caspase e usos dos mesmo | |
| AR002016A1 (es) | Derivados de 3-fenilisoquinoleina-1-(2h)-ona, procedimiento para su preparacion y medicamento y composicion farmaceutica que los contienen. | |
| KR950700314A (ko) | 루이스형 당쇄 유도체(Lewis-type sugar chain derivative) | |
| BRPI0417161A (pt) | compostos, composições farmacêuticas, e, uso de um composto | |
| BR0008302A (pt) | Uso de um derivado de benzaldeìdo, derivado de benzaldeìdo, composição farmacêutica, e, processo para a fabricação da mesma | |
| SE9904421D0 (sv) | New compounds | |
| BR0314352A (pt) | Indóis 2,7-substituìdos e seu uso como moduladores de 5-ht6 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA10 | Dismissal: dismissal - article 33 of industrial property law |